Anna has a successful track record in leading and driving transformational change within the pharmaceutical sector. She has significant Global business experience having held a variety of senior executive roles within NZ, Asia Pacific and Europe. Anna most recently retired from being the NZ General Manager of GlaxoSmthKline & she is now committed to growing businesses through best practice governance. Anna is also Deputy Chair of TAB NZ & Director of Rua Bioscience.